Properties of recombinant HtrA: an otitis media vaccine candidate antigen from non-typeable Haemophilus influenzae.

Cates, G A; Yang, Y P; Klyushnichenko, V; Oomen, R; Loosmore, S M

Cates, G A; Yang, Y P; Klyushnichenko, V; Oomen, R; Loosmore, S M.

Affiliation

Cates GA; Aventis Pasteur, Toronto, Ontario, Canada.

Dev Biol (Basel) ; 103: 201-4, 2000.

Article in En | MEDLINE | ID: mdl-11214237

Subject(s)

Antigens, Bacterial/chemistry; Haemophilus Vaccines/immunology; Otitis Media/prevention & control; Vaccines, Synthetic/immunology; Animals; Antigens, Bacterial/genetics; Antigens, Bacterial/immunology; Chinchilla/immunology; Circular Dichroism; Escherichia coli/metabolism; Haemophilus Vaccines/genetics; Mutation; Otitis Media/immunology; Protein Structure, Secondary; Rabbits; Vaccines, Synthetic/genetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Otitis Media / Vaccines, Synthetic / Haemophilus Vaccines / Antigens, Bacterial Limits: Animals Language: En Journal: Dev Biol (Basel) Journal subject: ALERGIA E IMUNOLOGIA Year: 2000 Type: Article Affiliation country: Canada

Search on Google

XML

PubMed Links